Stock Track | Vir Biotechnology (VIR) Soars 5.03% on Bullish Analyst Ratings

Stock Track

昨天

Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major financial institutions.

Morgan Stanley has reiterated its Buy rating on Vir Biotechnology, setting a price target of $20.00. This optimistic outlook suggests substantial upside potential for the stock. Additionally, TD Cowen has maintained its Buy rating on VIR, further bolstering investor confidence in the biotechnology company.

These positive assessments from respected Wall Street analysts appear to be driving the stock's impressive performance today. Investors are likely interpreting these Buy ratings as indicators of Vir Biotechnology's strong market position and growth prospects in the competitive biotech sector.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1190163920"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1190163920\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1190163920?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 03:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190163920","market":"sg","top_or_hot":-1,"title":"Stock Track | Vir Biotechnology (VIR) Soars 5.03% on Bullish Analyst Ratings","media":"Stock Track","content":"<p>Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major financial institutions.</p>\n\n<p>Morgan Stanley has reiterated its Buy rating on Vir Biotechnology, setting a price target of $20.00. This optimistic outlook suggests substantial upside potential for the stock. Additionally, TD Cowen has maintained its Buy rating on VIR, further bolstering investor confidence in the biotechnology company.</p>\n\n<p>These positive assessments from respected Wall Street analysts appear to be driving the stock's impressive performance today. Investors are likely interpreting these Buy ratings as indicators of Vir Biotechnology's strong market position and growth prospects in the competitive biotech sector.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Vir Biotechnology (VIR) Soars 5.03% on Bullish Analyst Ratings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Vir Biotechnology (VIR) Soars 5.03% on Bullish Analyst Ratings\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2025-11-12 03:20</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major financial institutions.</p>\n\n<p>Morgan Stanley has reiterated its Buy rating on Vir Biotechnology, setting a price target of $20.00. This optimistic outlook suggests substantial upside potential for the stock. Additionally, TD Cowen has maintained its Buy rating on VIR, further bolstering investor confidence in the biotechnology company.</p>\n\n<p>These positive assessments from respected Wall Street analysts appear to be driving the stock's impressive performance today. Investors are likely interpreting these Buy ratings as indicators of Vir Biotechnology's strong market position and growth prospects in the competitive biotech sector.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VIR","symbol_name":"Vir Biotechnology, Inc.","start_time":0,"source_url":"","article_id":"1190163920","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190163920","pubTimestamp":1762888830,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"VIR":"Vir Biotechnology, Inc."},"translate_title":"股票追踪|Vir Biotechnology(VIR)因分析师看涨评级飙升5.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VIR":1},"content_text":"Shares of Vir Biotechnology, Inc. (VIR) are surging in intraday trading, with the stock price soaring 5.03%. This significant uptick comes on the heels of bullish analyst ratings from two major financial institutions.\nMorgan Stanley has reiterated its Buy rating on Vir Biotechnology, setting a price target of $20.00. This optimistic outlook suggests substantial upside potential for the stock. Additionally, TD Cowen has maintained its Buy rating on VIR, further bolstering investor confidence in the biotechnology company.\nThese positive assessments from respected Wall Street analysts appear to be driving the stock's impressive performance today. Investors are likely interpreting these Buy ratings as indicators of Vir Biotechnology's strong market position and growth prospects in the competitive biotech sector.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}